Point-Of-Care Proteomic Assay Aids Bladder Cancer Detection – JAMA Study
This article was originally published in The Gray Sheet
Executive Summary
Matritech will use clinical data published in the Feb. 16 issue of the Journal of the American Medical Association to promote NMP22 BladderChek as an adjunctive tool to diagnose bladder cancer in high-risk patients